论文信息 - Population Pharmacokinetic Model Identifies an Optimal Fludarabine Exposure for Improved Outcomes after CD19-Directed CAR T Cell Therapy for Aggressive B-NHL: Analysis from the Cell Therapy Consortium - 字舞流文

Population Pharmacokinetic Model Identifies an Optimal Fludarabine Exposure for Improved Outcomes after CD19-Directed CAR T Cell Therapy for Aggressive B-NHL: Analysis from the Cell Therapy Consortium

P. Riedell | M. Gonen | M. Perales | D. Porter | S. Devlin | M. Bishop | S. Schuster | O. Oluwole | V. Bachanova | R. Maziarz | R. Shouval | L. Nastoupil | M. Scordo | L. Leslie | A. Ip | J. Maakaron | Ana Alarcon Tomas | Jamie Brower | J. Mcguirk | J. Flynn | A. Parascondola